Synagis (palivizumab) Disease Interactions
There is 1 disease interaction with Synagis (palivizumab):
Palivizumab (Includes Synagis) ↔ Platelet Disorders
Severe Potential Hazard, High plausibility
Applies to: Coagulation Defect, Thrombocytopathy, Thrombocytopenia
Palivizumab is administered by IM injection and the risk of bleeding is increased in the presence of platelet function disorders and/or thrombocytopenia. Therapy with palivizumab should be administered cautiously in patients with coagulation disorders or thrombocytopenia.
- "Product Information. Synagis (palivizumab)." Ross Product Division Pharmaceuticals, Columbus, OH.
More about Synagis (palivizumab)
- Synagis Side Effects
- During Pregnancy
- Dosage Information
- Compare Alternatives
- Pricing & Coupons
- Drug class: immune globulins
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.